银杏二萜内酯葡胺注射液治疗进展性脑卒中的临床试验研究

目的:探究银杏二萜内酯葡胺注射液治疗进展性脑卒中的临床疗效.方法:选取2019年4月～2020年3月期间73例进展性脑卒中患者开展临床研究,采用双色球法,划分对照组(n=36,常规西医治疗)和观察组(n=37,银杏二萜内酯葡胺注射液治疗),比较两组神经功能缺损(NIHSS)评分、日常生活能力量表(ADL)评分、临床疗效...

Clinical Trial of Ginkgolide Meglumine Injection in the Treatment of Progressive Stroke

Objective:To explore the clinical efficacy of ginkgolide meglumine injection in the treatment of progressive stroke.Methods:73 patients with progressive stroke from April 2019 to March 2020 were selected and divided into control group(n=36,conventional western medicine treatment)and observation group(n=37,ginkgolide meglumine injection treatment).NIHSS score,ADL score and clinical efficacy of the two groups were compared.Results:After treatment,the NIHSS score and ADL score of the observation group were lower than those of the control group;Compared with the control group,the clinical efficacy of the observation group was more significant,and the difference between the two groups was significant(P<0.05).Conclusion:The application of ginkgolide meglumine injection treatment in patients with progressive stroke has significant clinical effect,which can significantly improve the patient's neurological function and improve the ability of daily living.